Alkaline comet assay study with breast cancer patients: Evaluation of baseline and chemotherapy-induced DNA damage in non-target cells

Clinical and Experimental Medicine

Volumn 6, Issue 4, 2006, Pages 177-190

  Kopjar, N ^a   Milas, I ^b   Garaj Vrhovac, V ^a   Gamulin, M ^c  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Alkaline comet assay; Breast cancer; Chemotherapy protocols; DNA damage; Interindividual differences

Indexed keywords

ALKALINE EARTH METAL; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; NUCLEIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD DONOR; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMET ASSAY; COMPUTER ANALYSIS; DISEASE COURSE; DNA DAMAGE; FEMALE; GENOTOXICITY; HUMAN; LEUKOCYTE; MIGRATION; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIDE EFFECT;

ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL NUCLEUS; COMET ASSAY; CYCLOPHOSPHAMIDE; DNA; DNA DAMAGE; FEMALE; FLUOROURACIL; HUMANS; LEUKOCYTES; METHOTREXATE; MIDDLE AGED; STATISTICS;

EID: 33845904130     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-006-0113-8     Document Type: Article

References (62)

1. Polyak K (2001) On the birth of breast cancer. Biochim Biophys Acta 1552:1-13
2. Bignami M, Casorelli I, Karran P (2003) Mismatch repair and response to DNA-damaging antitumor therapies. Eur J Cancer 39:2142-2149
3. Saito I (1993) Chemistry of drug-induced DNA lesions. Toxicol Lett 67:3-15
4. Colombo P, Gunnarsson K, Iatropoulos M, Brughera M (2001) Toxicological testing of cytotoxic drugs (Review). Int J Oncol 19:1021-1028
5. Kelsey KT, Caggana M, Mauch PM, Coleman CN, Clark JR, Liber HL (1993) Mutagenesis after cancer therapy. Environ Health Persp [Suppl 101]:177-184
6. Elsendoorn TJ, Weijl NI, Mithoe S, Zwinderman AH, Van Dam F, De Zwart FA, Tates AD, Osanto S (2001) Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat Res 498:145-158
7. Bernard-Marty C, Mano M, Paesmans M, Accettura C, Munoz-Bermeo R, Richard T, Kleiber K, Cardoso F, Lobelle JP, Larismont D, Piccart MJ, Di Leo A (2003) Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regiment in adjuvant treatment of node-positive breast cancer patients. Ann Oncol 14:693-698
8. Karran P, Offman J, Bignami M (2003) Human mismatch repair, drug-induced DNA damage, and secondary cancer. Biochimie 85:1149-1160
9. Rigaud O, Guedeney G, Duranton I, Leroy A, Doloy MT, Magdelenat H (1990) Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II Alteration of DNA repair and chromosome radiosensitivity. Mutat Res 242:25-35
10. Mohernweiser HW, Jones IM (1998) Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res 400:15-24
11. Fairbairn DW, Olive PL, O'Neill KL (1995) The comet assay: a comprehensive review. Mutat Res 33:37-59
12. Collins A, Dušinska M, Franklin M, Somorovska M, Petrovska H, Duthie S, Fillion L, Panayiotidis M, Raslova K, Vaughan N (1997) Comet assay in human biomonitoring studies - reliability, validation, and applications. Environ Mol Mutagen 30:139-146
13. Olive PL (1999) Applications of the comet assay in radiobiology. Int J Radiat Biol 75:395-405
14. Piperakis SM, Visvardis EE, Tassiou AM (1999) Comet assay for nuclear DNA damage. Methods Enzymol 300:184-194
15. Rojas E, Lopez MC, Valverde M (1999) Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B 722:225-254
16. Singh NP (2000) Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis. Mutat Res 455:111-127
17. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/Comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221
18. Udumudi A, Jaiswal M, Rajeswari N, Desai N, Jain S, Balakrishna N, Visweswara R, Ahuja YR (1998) Risk assessment in cervical dysplasia patients by single cell gel electrophoresis assay: a study of DNA damage and repair. Mutat Res 412:195-205
19. Baltaci V, Kaikçioǧlu F, Alpas İ, Zeyneloǧlu H, Haberal A (2002) Sister chromatid exchange rate and alkaline comet assay scores in patients with ovarian cancer. Gynecol Oncol 84:62-66
20. Palyvoda O, Polańska J, Wygoda A, Rzezowska-Wolny J (2003) DNA damage and repair in lymphocytes of normal individuals and cancer patients: studies by the comet assay and micronucleus tests. Acta Biochim Polon 50:181-190
21. Colleu-Durel S, Guitton N, Nourgalieva K, Legue F, Lévêque J, Danic B, Chenal C (2004) Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 40:445-451
22. Sánchez P, Peñarroja R, Gallegos F, Bravo JL, Rojas E, Benítez-Bribiesca L (2004) DNA damage in peripheral lymphocytes of untreated breast cancer patients. Arch Med Res 35:480-483
23. Rajeswari N, Ahuja YR, Malini U, Chandrashekar S, Balakrishna N, Rao KV, Khar A (2000) Risk assessment in first degree female relatives of breast cancer patients using the alkaline comet assay. Carcinogenesis 21:557-561
24. Vaghef H, Nygren P, Edling C, Bergh J, Hellman B (1997) Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide. Mutat Res 395:127-138
25. Leprat F, Alapetite C, Roselli F, Ridet A, Schlumberger M, Sarasin A, Suarez H, Moustachi E (1998) Impaired DNA repair as assessed by the "comet" assay in patients with thyroid tumors after a history of radiation therapy: a preliminary study. Int J Radiat Oncol Biol Phys 40:1019-1026
26. Hartley JM, Spanswick VJ, Gander M, Giacomini G, Whelan J, Souhami RL, Hartley JA (1999) Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (Comet) assay. Clin Cancer Res 5:507-512
27. Braybrooke J, Houlbrook S, Crawley JE, Propper DJ, O'Byrne KJ, Stratford IJ, Harris AL, Shuker DEG, Talbot DC (2000) Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen. Cancer Chemother Pharmacol 45:111-119
28. Kopjar N, Garaj-Vrhovac V, Milas I (2002) Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay. Teratogen Carcinogen Mutagen 22:13-30
29. Blasiak J, Arabski M, Krupa R, Wozniak K, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Zadrozny M (2004) Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res 554:139-148
30. National Comprehensive Cancer Network (2005) Clinical Practice Guidelines in Oncology. Breast cancer, pp 1-72
31. Singh NP, McCoy MT, Tice RR, Schneider LL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191
32. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG, Tice R, Waters MD, Aitio A (2000) ICPS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111-172
33. Betti C, Davini T, Giannessi L, Loprieno N, Barale R (1994) Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjects. Mutat Res 307:323-333
34. Poli P, Buschini A, Spaggiari A, Rizzoli V, Carlo-Stella C, Rossi C (1999) DNA damage by tobacco smoke and some antiblastid drugs evaluated using the Comet assay. Toxicol Lett 108:267-276
35. Del Mastro L, Costantini M, Morasso G, Bonci F, Bergaglio M, Banducci S, Viterbori P, Conte R, Venturini M (2002) Impact of two different dose-intensity regiments on psychological distress in early breast cancer patients. Eur J Cancer 38:359-366
36. Harris LN, Yang L, Liotcheva V, Pauli S, Iglehart JD, Colvin OM, Hsieh TS (2001) Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy. Clin Cancer Res 7:1497-1504
37. Buzdar AU, Kau SW, Smith TL, Hortobagyi GN (1989) Ten-year results of FAC adjuvant chemotherapy trial in breast cancer. Am J Clin Oncol 12:123-128
38. Esteva FJ, Hortobagyi GN (1998) Integration of systemic chemotherapy in the management of primary breast cancer. Oncologist 3:300-313
39. Esteva FJ, Valero V, Pusztai L, Bohenke-Michaud L, Buzdar AU, Hortobagyi GN (2001) Chemotherapy for metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6:133-146
40. Colloza M, Bisagni G, Mosconi AM, Gori S, Boni C, Sabbatini R, Frassoldati A, Passalacqua R, Rosa Bian A, Rodinò C, Rondini E, Alegri R, Di Sarra S, De Angelis V, Cocconi G, Tonato M, on behalf of the Italian Oncology Group for Clinical Research (GOIRC) (2002) Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study. Eur J Cancer 38:2279-2288
41. Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C (1998) Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Canc Res Clin Oncol 124:207-214
42. Diamandidou E, Buzdar AU, Smith TL, Frye D, Witjaksono M, Hortobagyi GN (1996) Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 14:2722-2730
43. Olinski R, Jaruga P, Foksinski M, Bialkowski K, Tujakowski J (1997) Epirubicin-induced oxidative DNA damage and evidence for its repair in lymphocytes of cancer patients who are undergoing chemotherapy. Mol Pharmacol 2:882-885
44. Blasiak J, Widera K, Petryński T (2003) Hyperthermia can differentially modulate the repair of doxorubicin-damaged DNA in normal and cancer cells. Acta Biochim Polon 50:191-195
45. Hellman B, Vaghef H, Friis L, Edling C (1997) Alkaline single cell gel electrophoresis of DNA fragments in biomonitoring for genotoxicity: an introductory study on healthy human volunteers. Int Arch Occup Environ Health 69:185-192
46. Liu X, Zhao J, Zheng R (2003) DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res 539:1-8
47. Jałoszyńsky P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K (1997) Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 385:223-233
48. Çeçener G, Egeli Ü, Taşdelan I, Tunca B, Duman H, Kizil A (1998) Common fragile site expression and genetic predisposition to breast cancer. Teratogen Carcinogen Mutagen 18:279-291
49. Rothfuss A, Schütz, P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA 1 mutation in breast cancer families. Cancer Res 60:390-394
50. Gebhart E, Romahn R, Schneider A, Hoffmann M, Rau D, Tittelbach H (1993) Cytogenetic studies in lymphocytes of patients with rectal cancer. Environ Health Persp 101[Suppl 3]:169-175
51. Felici A, Verweij J, Sparreboom A (2002) Dosing strategies for anticancer drugs: the good, the bad and body-surface area. Eur J Cancer 38:1677-1684
52. Eastman A, Barry MA (1992) The origins of DNA strand breaks: A consequence of DNA damage, DNA repair or apoptosis. Cancer Invest 10:229-240
53. Noviello E, Aluigi MG, Cimoli G, Rovini E, Mazzoni A, Parodi S, De Sessa F, Russo P (1994) Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks. Mutat Res 311:21-29
54. Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727-741
55. Siu WY, Arooz T, Poon RY (1999) Differential responses of proliferating versus quiescent cells to adriamycin. Exp Cell Res 250:131-141
56. Maskaleris T, Lialiaris T, Triantaphyllidis C (1998) Induction of cytogenetic damage in human lymphocytes in vitro and of antineoplastic effects in Erlich ascites tumor cells in vivo treated by methotrexate, hyperthermia and/or caffeine. Mutat Res 422:229-236
57. Fortini P, Raspaglio G, Falchi M, Dogliotti E (1996) Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis 11:169-175
58. Ochs K, Sobol RW, Wilson SH, Kaina B (1999) Cells deficient in DNA polymerase β are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. Cancer Res 59:1544-1551
59. Olive P, Banáth JP (1995) Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp Cell Res 221:19-26
60. Miyamae Y, Zaizen K, Ohara K, Mine Y, Sasaki YF (1998) Detection of DNA lesions induced by chemical mutagens by the single cell electrophoresis (Comet) assay 1. Relationship between the onset of DNA damage and the characteristics of mutagens. Mutat Res 415:229-235
61. Wojewódzka M, Kruszewski M, Iwanenko T, Collins AR, Szumiel I (1999) Lack of adverse effect of smoking habit on DNA strand breakage and base damage, as revealed by the alkaline comet assay. Mutat Res 440:19-25
62. Anderson D, Bishop JB, Colin Garner R, Ostrosky-Wegman P Selby PB (1995) Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res 330:115-181